|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
US
|
|
Melinta Therapeutics, Inc. (MLNT) is the largest pure-play antibiotics company, dedicated to saving lives threatened by the global public health crisis of bacterial infections through the development and commercialization of novel antibiotics that provide new therapeutic solutions. Its four marketed products include Baxdela® (delafloxacin), Vabomere® (meropenem and vaborbactam), Orbactiv® (oritavancin), and Minocin® (minocycline) for Injection. This portfolio provides Melinta with the unique ability to provide providers and patients with a range of solutions that can meet the tremendous need for novel antibiotics treating serious infections. Visit www.melinta.com for more information.
|
Melinta Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Melinta Therapeutics email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Melinta Therapeutics customer service number in your country click here to find.
Christine Ann Miller is the CEO of Melinta Therapeutics. To contact Christine Ann Miller email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.